Comparison of Rigid and Non-Rigid Interbody Fusion Device for Cervical Degenerative Disc Disease in Adults

Key facts

Sponsor

National Taiwan University Hospital

Intervention

Z-Brace interbody fusion device(combination_product)

Enrollment

180 enrolled

Eligibility

20-69 years · All sexes

Timeline

2020 – 2025

Study locations (13)

• Chung Shan Medical University Hospital, Taichung, South Dist., Taiwan
• Fu Jen Catholic University Hospital, New Taipei City, Taishan District, Taiwan
• Taipei Municipal Wan Fang Hospital, Taipei, Wenshan Dist., Taiwan
• National Taiwan University Hospital Yunlin Branch, Douliu, Yunlin County, Taiwan
• Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare, New Taipei City, Zhonghe District, Taiwan
• MacKay Memorial Hospital, Taipei, Zhongshan, Taiwan
• National Taiwan University Hospital, Taipei, Zhongzheng Dist., Taiwan
• National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan
• China Medical University Hospital, Taichung, Taiwan
• Jen-Ai Hospital Dali Branch, Taichung, Taiwan
• National Cheng Kung University Hospital, Tainan, Taiwan
• Min-Sheng General Hospital, Taoyuan, Taiwan
• Chang Gung Memorial Hospital, Taoyuan, Taiwan

Collaborators

Baui Biotech Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• RECRUITINGPHASE2NCT07328503
  CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
  National Cancer Institute (NCI)
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• ENROLLING BY INVITATIONNCT07515430
  The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
  Sun Yat-sen University

See all trials for Acute lymphoblastic leukemia →